XTX301XTX301-treatedmetastatic solid tumorsAdvarra Institutional Review Board
…e 2, days 2-5) from a head and neck cancer patient treated with XTX301. (A) Immunohistochemistry: CD8+ T cells (percentage of Tumor-In…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 181–240 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Clarithromycin17Antibiotic17Anticoagulants17fludarabine17Inclisiran16Atropine16Secukinumab16Caffeine16Salbutamol16Ondansetron16Dapagliflozin16Naloxone16Methylene blue16Anakinra16Fluconazole16Rilpivirine16Analgesics16Rocuronium16Proton pump inhibitor16Osimertinib15Atogepant15ELAFIBRANOR15Pirfenidone15Dabigatran15Obinutuzumab15Rosuvastatin15Medicines15Amphotericin B15Ketorolac15Carbon Monoxide15ACE inhibitors15Phenylephrine15Glucocorticoid15non-steroidal anti-inflammatory drugs15Empagliflozin14Rimegepant14Fremanezumab14FeNO14Olaparib14GA14Relatlimab14IL-1214Lactulose14SpironolacTone14Mannitol14Levothyroxine14bleomycin14Sodium-glucose cotransporter 2 inhibitors14Beta Blockers14Axicabtagene Ciloleucel14adrenaline14Broad-spectrum antibiotics14Etoposide14Tenofovir14Intravenous Immunoglobulin14UPA13LMWH13Liposomal bupivacaine13Baricitinib13Ruxolitinib13
Articles mentioning drugs
10,506 articles · page 146 of 876TTX-080pembrolizumabcetuximabsolid tumorsmetastatic or advanced cancer
…al immunotherapy approaches to date.Conclusions Taken together, TTX-080 offers a differentiated mechanism-of-action that has the potent…
ES009colorectal cancersubmandibular gland cancerovarian cancercholangiocarcinomanon-small cell lung canceradvanced solid tumorsBellberry Human Research Ethics Committee
…K), pharmacodynamics (PD), and preliminary clinical activity of ES009.Methods This open-label, multicenter, non-randomized Phase 1 st…
96.6%
mANK-101entinostatANK-101CT26MOC-1solid malignanciesHPV16 neg head and neck
…llow for an in-depth understanding of the synergistic effect of mANK-101 with HDAC inhibition.Conclusions Collectively, these findings p…
BiCo-3CD276xCD3 bsAb CC-3bsAbssolid tumorsUniversity Hospital TuebingenNCT05999396Eberhard Karls Universitaet Tuebingen
…gens expressed on distinct tumor and stromal cell compartments. BiCo-3 enhances efficacy of CD3-directed bsAbs across a broad range of…
etrumadenantzimberelimabdomvanalimabNSCLCWashington Universitymetastatic non-small cell lung cancer
…relimab 360mg IV q3 weeks, domvanalimab 15mg/kg IV q3 weeks and etrumadenant 150mg PO daily. The primary endpoint was objective response rat…
DaraxonrasibelironrasibpembrolizumabNSCLCanti-PD-1 immunotherapyimmunotherapy
… cancer (NSCLC) where immunotherapy is standard of care.Methods Daraxonrasib, a RAS(ON) multi-selective inhibitor, and elironrasib, a RAS(ON…
docetaxelatezolizumabtasquinimodS100A8/A9NSCLC
… as well as pathway analysis using MsigDB. Patient outcomes for docetaxel and atezolizumab were assessed in OAK and POPLAR clinical trial…
nivolumabipilimumabrelatlimabMucosal melanomaInova Schar Cancer Institutelocally advanced mucosal melanoma
…t-remission, one of whom achieved CR after salvage therapy with nivolumab. Among the 4 patients who were treated with relatlimab and nivo…
IL-15IL-2IL-7GDF-15Hepatocellular carcinoma (HCC)hepatocellular carcinomaHCCChimeric antigen receptor natural killer cell (CAR-NK) therapy
… vitro with different doses of cytokines, including IL-2, IL-7, IL-15. IL-2 stimulated human NK cells were co-cultured with human HCC…
6MHPcyclophosphamide12MPMel44University of VirginiaFox Chase Cancer CentermelanomaMD Anderson Cancer CenterClinicalTrials.gov
…on of memory CD8 + T cells in a pilot experiment and found that 6MHP vaccine preserved memory CD8+ T cells, providing initial suppor…
αCD45-IL12IL-12autochthonous lung adenocarcinomasmurine lung cancersautochthonous lung tumors
…preciated role for IL-12 in directly modulating DCs and support αCD45-IL12 as a promising strategy for ICB-resistant lung cancer.Acknowled…